Enhancing the Evaluation of Opicapone in Early Wearing‐Off Symptoms of Parkinson's Disease: A Critical Review and Recommendations for Future Research

Documenti analoghi

• Opicapone in Parkinson's Disease on Levodopa‐Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study
  di: Fabiana Colucci, et al.
  Pubblicazione: (2025)
• Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease
  di: Maria Teresa Pellecchia, et al.
  Pubblicazione: (2025)
• Enhancing the Applicability and Robustness of a Prognostic Model for Parkinson's Disease: Suggestions for Future Research
  di: Kaili Lin, et al.
  Pubblicazione: (2025)
• Improving Insight and Application: A Commentary on the Link between Initial Depression and Anxiety and Long‐Term Health Outcomes in Parkinson's Disease Patients
  di: Xiaolong Guo, et al.
  Pubblicazione: (2024)
• The Menstrual Cycle and Pregnancy Commonly Impact Symptoms of Women with Early‐Onset Parkinson's Disease
  di: Ingeborg H. Lie, et al.
  Pubblicazione: (2025)